Depression in quarantined patients during the COVID-19 pandemic

Guermazi, A.; Thabet, J. Ben Zouari A.; Aloulou, J.; Hammami, R.; Ayed, H. Ben Sallemi A.; Marrekchi, C.; Hdiji, S.; Gargouri, I.; Kassis, M.; Turki, M.; Kammoun, S.; Masmoudi, M. Larbi

IntroductionQuarantine for suspected patients of being infected by the COVID-19 can lead to negative consequences for mental health and the appearance of depressive symptoms.ObjectivesTo assess the prevalence of depression in quarantined patients, and to analyze the associated factors.MethodsThis was a descriptive and analytical survey, carried out from April 4 to May 30, 2020, with 149 patients consulting the COVID-19 sorting box at the Hedi Chaker CHU in Sfax. Suspected COVID-19 patients were contacted by phone during their quarantine and invited to participate in our study. The Patient Health Questionnaire (PHQ-9) scale was used to assess the severity of depression. Cutoffs of 5, 10, 15, and 20 represent minimal, mild, moderate, moderately severe, and severe levels of depression based on PHQ-9 scores. A cutoff score of 10 determines major depression.ResultsThe results showed a prevalence of major depression of 10.7%. Of all patients, 89.3% had minimal to mild depression;10% had moderate to moderately severe depression and 0.7% had severe depression. The PHQ-9 score was statistically correlated with travel to a suspect area during the 14 days preceding the consultation (p = 0.008), contact with a subject confirmed COVID-19 (p = 0.01), previous follow-up in psychiatry (p = 0.047), the change of residence during quarantine (p = 0.045), the fear of transmitting the disease to relatives (p = 0.00) and the positive result of the nasopharyngeal swab (p = 0.00).ConclusionsPsychological distress was felt in our patients. We recommend that necessary measures should be taken to combat depression.